Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis

Published:2020-05-07 Issue:7 Volume:4 Page:1034-1040
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Violi Francesco¹,Vestri Annarita²,Menichelli Danilo¹,Di Rocco Arianna²,Pastori Daniele¹^ORCID,Pignatelli Pasquale¹

Affiliation:

1. I Clinica Medica Atherothrombosis Center Department of Clinical Internal, Anesthesiologic, and Cardiovascular Sciences Sapienza University of Rome Rome Italy

2. Department of Public Health and Infectious Diseases Sapienza University of Rome Rome Italy

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1513

Reference16 articles.

1. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

3. Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis

4. Non‐vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease: a meta‐analysis and systematic review;Fu Y;Am J Cardiovasc Drugs

5. Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies;The Lancet Gastroenterology & Hepatology;2024-09

2. Risk of Adverse Events in Anticoagulated Patients With Atrial Fibrillation and Nonalcoholic Fatty Liver Disease;The Journal of Clinical Endocrinology & Metabolism;2024-06-12

3. Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis;International Journal of Molecular Sciences;2023-08-13

4. Diseases of the gastrointestinal tract coronary heart disease: relationships and mutual influences;Experimental and Clinical Gastroenterology;2023-07-25

5. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis;Journal of Hepatology;2023-07